Comprehensive DOTS-aligned management of pulmonary and extra-pulmonary tuberculosis.
Comprehensive DOTS-aligned management of pulmonary and extra-pulmonary tuberculosis, including drug-resistant TB — with adherence support and side-effect monitoring throughout therapy.
Tuberculosis remains a major public-health problem in India. We offer end-to-end TB care — from smear, GeneXpert MTB/RIF and LPA-based diagnosis to daily fixed-dose combination ATT, side-effect monitoring, drug-resistant TB regimens (including shorter oral BPaL/BPaLM where applicable) and long-term follow-up in line with NTEP guidelines.
Drug-sensitive pulmonary TB is treated for 6 months. MDR-TB regimens range from 6–9 months (shorter oral BPaL/BPaLM in eligible patients) to 18–24 months in complex cases.
Most patients can continue work after the first 2–4 weeks once they are smear-negative and clinically improved, subject to occupational risk assessment.
GeneXpert MTB/RIF and LPA test for rifampicin and INH resistance directly on sputum, usually giving results within a day or two.
Yes — under NTEP, first- and second-line anti-TB drugs are provided free of cost. We coordinate free-drug supply along with clinic follow-up.
Yes — post-TB lung disease can cause chronic cough, bronchiectasis or reduced lung function. Long-term pulmonology follow-up is important.
The information above is educational and does not replace an in-person consultation. For a personalised plan, book with Dr Saurabh Bhatt (MD Pulmonology) at Samarth Chest Hospital & ICU, 4th Floor, RK Casta, Bharuch — call +91 90161 12968 or WhatsApp us.